Novavax（NASDAQ:NVAX）報告季度每股虧損0.51美元，與分析師的共識預期一致。與去年同期每股虧損1.47美元相比，這一數字增加了65.31%。該公司報告季度銷售額為8831萬美元，超過了分析師共識預期的8438萬美元，增幅為4.66%。與去年同期的銷售額2.9134億美元相比，這一數字下降了69.69%。

以上內容來自Benzinga Earnings專欄，原文如下：

Novavax (NASDAQ:NVAX) reported quarterly losses of $(0.51) per share which met the analyst consensus estimate. This is a 65.31 percent increase over losses of $(1.47) per share from the same period last year. The company reported quarterly sales of $88.31 million which beat the analyst consensus estimate of $84.38 million by 4.66 percent. This is a 69.69 percent decrease over sales of $291.34 million the same period last year.